Statistics for Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Total visits
| views | |
|---|---|
| Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial | 4 |
Total visits per month
| views | |
|---|---|
| January 2025 | 4 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| SAFETY~1.PDF | 42 |
Top country views
| views | |
|---|---|
| Chile | 4 |
Top city views
| views | |
|---|---|
| Santiago | 4 |